MGNX

SEC filing MGNX Shareholders Elect Directors, Ratify Ernst & Young, Approve Executive Pay, and Authorize 1.25M Additional Shares under 2023 Equity Plan

12d ago

News MacroGenics Revenue Doubles in Q2

14d ago

News Demystifying Macrogenics: Insights From 14 Analyst Reviews

14d ago

News At a glance: stocks gapping up premarket

21d ago

News MacroGenics to sell manufacturing operations to Bora for $122.5M

21d ago

SEC filing MGNX Reports $60M Upfront, Up to $20M Milestone, Expanded Royalty Deal with Sagard

28d ago

News MacroGenics gains removal of FDA partial hold on lead program

54d ago

News Incyte fails to win FDA label expansion for cancer therapy due to issues at Novo plant

87d ago

News MacroGenics drops after FDA partial clinical hold on lead program

98d ago

News Incyte wins EU backing for MacroGenics-partnered cancer drug in GIT indication

122d ago

Scanner Unusual volume (z=6.7)

165d ago